These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2262756)

  • 21. Growth hormone receptor expression in brain tumors.
    Sakoguchi T; Hama S; Tominaga A; Kinoshita Y; Sugiyama K; Arita K; Kurisu K
    Hiroshima J Med Sci; 2012 Mar; 61(1):1-6. PubMed ID: 22702213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion.
    Trouillas J; Daniel L; Guigard MP; Tong S; Gouvernet J; Jouanneau E; Jan M; Perrin G; Fischer G; Tabarin A; Rougon G; Figarella-Branger D
    J Neurosurg; 2003 May; 98(5):1084-93. PubMed ID: 12744370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary adenomas. Immunocytochemical study of 150 tumors with clinicopathologic correlation.
    Mukai K
    Cancer; 1983 Aug; 52(4):648-53. PubMed ID: 6190550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histologic and immunohistochemical study of clinically non-functioning pituitary adenomas: special reference to gonadotropin-positive adenomas.
    Sano T; Yamada S
    Pathol Int; 1994 Sep; 44(9):697-703. PubMed ID: 7804432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Neuropeptide Y and Its Relationship with Molecular and Morphological Changes in Human Pituitary Adenomas.
    Jia R; Li M; Chang B; Chen L; Ma J
    Cancer Biother Radiopharm; 2015 Dec; 30(10):411-9. PubMed ID: 26683132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ras mutations in human pituitary tumors.
    Karga HJ; Alexander JM; Hedley-Whyte ET; Klibanski A; Jameson JL
    J Clin Endocrinol Metab; 1992 Apr; 74(4):914-9. PubMed ID: 1312542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In situ hybridization for different mRNA in GH-secreting and in inactive pituitary adenomas.
    Saeger W; Uhlig H; Bäz E; Fehr S; Lüdecke DK
    Pathol Res Pract; 1991 Jun; 187(5):559-63. PubMed ID: 1923947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone production in clinically nonfunctioning pituitary adenomas.
    Black PM; Hsu DW; Klibanski A; Kliman B; Jameson JL; Ridgway EC; Hedley-Whyte ET; Zervas NT
    J Neurosurg; 1987 Feb; 66(2):244-50. PubMed ID: 3543255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary adenomas associated with hyperprolactinemia: a clinical and immunohistochemical study of 97 patients operated on transsphenoidally.
    Randall RV; Scheithauer BW; Laws ER; Abbound CF; Ebersold MJ; Kao PC
    Mayo Clin Proc; 1985 Nov; 60(11):753-62. PubMed ID: 3932786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary macroadenomas (>3 cm) in young adulthood: Pathologic and proliferative characteristics.
    Öngürü Ö; Düz B; Şimşek H; Günal A; Gönül E
    Neurol Neurochir Pol; 2015; 49(4):212-6. PubMed ID: 26188936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunocytochemistry of pituitary tumors.
    Heitz PU; Landolt AM; Zenklusen HR; Kasper M; Reubi JC; Oberholzer M; Roth J
    J Histochem Cytochem; 1987 Sep; 35(9):1005-11. PubMed ID: 2440942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation analysis of anterior pituitary hormone and tumor size in patients with pituitary adenomas].
    Wang YP; Li YJ; Li B; Zang L; Chen K; Du J; Dou JT; Lyu ZH; Gu WJ; Mu YM
    Zhonghua Nei Ke Za Zhi; 2023 Aug; 62(8):979-986. PubMed ID: 37528036
    [No Abstract]   [Full Text] [Related]  

  • 33. Sellar gangliocytoma with adrenocorticotropic and prolactin adenoma.
    Kissiedu JO; Prayson RA
    J Clin Neurosci; 2016 Feb; 24():141-2. PubMed ID: 26314658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Volumes of pituitary adenomas related to hormone production, duration of symptoms and postoperative outcome.
    Reinlie S; Haakonsen M; Eldevik OP; Nesbakken R
    Acta Radiol Suppl; 1986; 369():306-9. PubMed ID: 2980482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Observation of Clinicopathologic Features of Pituitary Adenoma With Neuronal Differentiation.
    Zheng L; Yan X; Hu C; Zhang P; Chen Y; Zheng Q; Hu L; Wang M; Li G; Wu P; Jiang C; Tian J; Zhang S; Wang X
    Front Endocrinol (Lausanne); 2022; 13():848762. PubMed ID: 35370935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In situ hybridization histochemistry of mRNAs for hormones and chromogranins in normal pituitary tissue and pituitary adenoma.
    Kilár F; Muhr C; Funa K
    Acta Endocrinol (Copenh); 1991 Dec; 125(6):628-36. PubMed ID: 1789058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly.
    Mendes GA; Haag T; Trott G; Rech CGSL; Ferreira NP; Oliveira MC; Kohek MB; Pereira-Lima JFS
    Braz J Med Biol Res; 2017 Dec; 51(2):e6808. PubMed ID: 29267504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pituitary tumors and hyperprolactinemia.
    Malarkey WB; Johnson JC
    Arch Intern Med; 1976 Jan; 136(1):40-4. PubMed ID: 1247335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Bcl-2, Bax and p53 proteins in pituitary adenomas: an immunohistochemical study.
    Ozer E; Canda MS; Ulukus C; Guray M; Erbayraktar S
    Tumori; 2003; 89(1):54-9. PubMed ID: 12729363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors.
    Greenman Y; Melmed S
    J Clin Endocrinol Metab; 1994 Feb; 78(2):398-403. PubMed ID: 8106629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.